Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|8|1|62-68

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.8, Iss.1, 2008-03, pp. : 62-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Dirks Nathanael L.   Meibohm Bernd  

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 633-659

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Keizer Ron J.   Huitema Alwin D.R.   Schellens Jan H.M.   Beijnen Jos H.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 493-507

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies

By Yan Li   Davis Hugh M  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 961-964

Future Medicine

Access to resources Recommend Favorite

Primary biliary cholangitis associated with warm autoimmune hemolytic anemia

By  

Journal of Digestive Diseases, Vol. 17, Iss. 2, 2016-02 ,pp. : 128-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case‐based approach

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 258-261

John Wiley & Sons Inc

Access to resources Recommend Favorite